CN1286468C - 含藻酸或藻酸盐的药物组合物 - Google Patents
含藻酸或藻酸盐的药物组合物 Download PDFInfo
- Publication number
- CN1286468C CN1286468C CNB2004100461678A CN200410046167A CN1286468C CN 1286468 C CN1286468 C CN 1286468C CN B2004100461678 A CNB2004100461678 A CN B2004100461678A CN 200410046167 A CN200410046167 A CN 200410046167A CN 1286468 C CN1286468 C CN 1286468C
- Authority
- CN
- China
- Prior art keywords
- alginate
- compositions
- acid residue
- ratio
- total amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920000615 alginic acid Polymers 0.000 title claims abstract description 151
- 235000010443 alginic acid Nutrition 0.000 title claims abstract description 150
- 239000000203 mixture Substances 0.000 title claims abstract description 125
- 229960001126 alginic acid Drugs 0.000 title claims abstract description 28
- 239000000783 alginic acid Substances 0.000 title claims abstract description 28
- 150000004781 alginic acids Chemical class 0.000 title claims abstract description 28
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims abstract description 124
- 229940072056 alginate Drugs 0.000 claims abstract description 123
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical group OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 claims abstract description 41
- 125000005613 guluronic acid group Chemical group 0.000 claims abstract description 37
- 210000004400 mucous membrane Anatomy 0.000 claims abstract description 22
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 8
- 210000002784 stomach Anatomy 0.000 claims description 35
- 210000000936 intestine Anatomy 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 24
- 239000011241 protective layer Substances 0.000 claims description 22
- -1 alkali metal hydrogencarbonate Chemical class 0.000 claims description 19
- 229910052783 alkali metal Inorganic materials 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 16
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims description 16
- 208000000689 peptic esophagitis Diseases 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 14
- 208000007882 Gastritis Diseases 0.000 claims description 12
- 208000008469 Peptic Ulcer Diseases 0.000 claims description 12
- 201000006549 dyspepsia Diseases 0.000 claims description 12
- 208000011906 peptic ulcer disease Diseases 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- 229910021645 metal ion Inorganic materials 0.000 claims description 10
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 7
- 229910001424 calcium ion Inorganic materials 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 239000003431 cross linking reagent Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 230000002669 organ and tissue protective effect Effects 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 2
- 230000002496 gastric effect Effects 0.000 abstract description 3
- 239000011253 protective coating Substances 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 235000010413 sodium alginate Nutrition 0.000 description 47
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 46
- 239000000661 sodium alginate Substances 0.000 description 46
- 229940005550 sodium alginate Drugs 0.000 description 46
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 28
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 238000003756 stirring Methods 0.000 description 18
- 239000008367 deionised water Substances 0.000 description 16
- 229910021641 deionized water Inorganic materials 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 210000003238 esophagus Anatomy 0.000 description 14
- 229910000019 calcium carbonate Inorganic materials 0.000 description 13
- 235000010216 calcium carbonate Nutrition 0.000 description 13
- 210000004877 mucosa Anatomy 0.000 description 13
- 235000017557 sodium bicarbonate Nutrition 0.000 description 13
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000013355 food flavoring agent Nutrition 0.000 description 12
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 10
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 229940085605 saccharin sodium Drugs 0.000 description 10
- 239000006260 foam Substances 0.000 description 9
- 239000000758 substrate Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 230000003232 mucoadhesive effect Effects 0.000 description 7
- 239000000375 suspending agent Substances 0.000 description 7
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 6
- 235000019796 monopotassium phosphate Nutrition 0.000 description 6
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 241000195493 Cryptophyta Species 0.000 description 5
- 108010063954 Mucins Proteins 0.000 description 5
- 102000015728 Mucins Human genes 0.000 description 5
- 230000002421 anti-septic effect Effects 0.000 description 5
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 5
- 229920001222 biopolymer Polymers 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 5
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 5
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 5
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- REDXJYDRNCIFBQ-UHFFFAOYSA-N aluminium(3+) Chemical compound [Al+3] REDXJYDRNCIFBQ-UHFFFAOYSA-N 0.000 description 4
- 210000001156 gastric mucosa Anatomy 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000120 Artificial Saliva Substances 0.000 description 3
- 241001491705 Macrocystis pyrifera Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003364 biologic glue Substances 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 239000011736 potassium bicarbonate Substances 0.000 description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 3
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229960004291 sucralfate Drugs 0.000 description 3
- MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241000199919 Phaeophyceae Species 0.000 description 2
- 241000737023 Zebrasoma flavescens Species 0.000 description 2
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- 230000001458 anti-acid effect Effects 0.000 description 2
- 230000001078 anti-cholinergic effect Effects 0.000 description 2
- 239000000227 bioadhesive Substances 0.000 description 2
- 229960000530 carbenoxolone Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229940126409 proton pump inhibitor Drugs 0.000 description 2
- 239000000612 proton pump inhibitor Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VQJMAIZOEPPELO-KYGIZGOZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxy-5-methylhexan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol hydrochloride Chemical compound Cl.CO[C@]12CC[C@@]3(C[C@@H]1C(C)(O)CCC(C)C)[C@H]1Cc4ccc(O)c5O[C@@H]2[C@]3(CCN1CC1CC1)c45 VQJMAIZOEPPELO-KYGIZGOZSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AZLKCVHYSA-N (2r,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical group O[C@@H]1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-AZLKCVHYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-SYJWYVCOSA-N (2s,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical group O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-SYJWYVCOSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241001392689 Ecklonia maxima Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010009066 Gastric Mucins Proteins 0.000 description 1
- 102000009338 Gastric Mucins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- IAJILQKETJEXLJ-SQOUGZDYSA-N L-guluronic acid Chemical compound O=C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-SQOUGZDYSA-N 0.000 description 1
- 241001598113 Laminaria digitata Species 0.000 description 1
- 241000296380 Laminaria hyperborea Species 0.000 description 1
- 241001260563 Lessonia nigrescens Species 0.000 description 1
- PQMWYJDJHJQZDE-UHFFFAOYSA-M Methantheline bromide Chemical compound [Br-].C1=CC=C2C(C(=O)OCC[N+](C)(CC)CC)C3=CC=CC=C3OC2=C1 PQMWYJDJHJQZDE-UHFFFAOYSA-M 0.000 description 1
- 108010008705 Mucin-2 Proteins 0.000 description 1
- 102100034263 Mucin-2 Human genes 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229920000148 Polycarbophil calcium Polymers 0.000 description 1
- 241000190932 Rhodopseudomonas Species 0.000 description 1
- 241000015177 Saccharina japonica Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- LCWAOCHOPBSGMU-UHFFFAOYSA-J aluminum;magnesium;sodium;hydrogen carbonate;oxygen(2-);silicon;trihydroxide Chemical compound [OH-].[OH-].[OH-].[O-2].[Na+].[Mg+2].[Al+3].[Si].OC([O-])=O LCWAOCHOPBSGMU-UHFFFAOYSA-J 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 1
- 229960005132 cisapride Drugs 0.000 description 1
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- AEMOLEFTQBMNLQ-YBSDWZGDSA-N d-mannuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-YBSDWZGDSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000028299 esophageal disease Diseases 0.000 description 1
- 208000006881 esophagitis Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229940045140 gaviscon Drugs 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 235000012254 magnesium hydroxide Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229940023569 palmate Drugs 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229950005134 polycarbophil Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002325 prokinetic agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 229960001407 sodium bicarbonate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9708773.8 | 1997-04-30 | ||
| GBGB9708772.0A GB9708772D0 (en) | 1997-04-30 | 1997-04-30 | Organic compositions |
| GB9708772.0 | 1997-04-30 | ||
| GBGB9708773.8A GB9708773D0 (en) | 1997-04-30 | 1997-04-30 | Organic compositions |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB98804594XA Division CN1197584C (zh) | 1997-04-30 | 1998-04-23 | 可倾倒的藻酸盐组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1552344A CN1552344A (zh) | 2004-12-08 |
| CN1286468C true CN1286468C (zh) | 2006-11-29 |
Family
ID=26311463
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100461678A Expired - Fee Related CN1286468C (zh) | 1997-04-30 | 1998-04-23 | 含藻酸或藻酸盐的药物组合物 |
| CNB98804594XA Expired - Lifetime CN1197584C (zh) | 1997-04-30 | 1998-04-23 | 可倾倒的藻酸盐组合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB98804594XA Expired - Lifetime CN1197584C (zh) | 1997-04-30 | 1998-04-23 | 可倾倒的藻酸盐组合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6395307B1 (OSRAM) |
| EP (2) | EP1842544A3 (OSRAM) |
| JP (1) | JP2001522368A (OSRAM) |
| KR (1) | KR20010020438A (OSRAM) |
| CN (2) | CN1286468C (OSRAM) |
| AR (1) | AR012621A1 (OSRAM) |
| AU (1) | AU740972B2 (OSRAM) |
| BR (1) | BR9809310A (OSRAM) |
| CA (1) | CA2288743C (OSRAM) |
| ID (1) | ID23809A (OSRAM) |
| PL (3) | PL195031B1 (OSRAM) |
| WO (1) | WO1998048814A1 (OSRAM) |
| ZA (1) | ZA983707B (OSRAM) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0005743D0 (en) * | 2000-03-10 | 2000-05-03 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions including alginates |
| IL149030A0 (en) * | 2000-08-09 | 2002-11-10 | Panacea Biotec Ltd | Pharmaceutical compositions containing rifampicin, isoniazid or combinations thereof |
| GB0107651D0 (en) * | 2001-03-27 | 2001-05-16 | Syngenta Ltd | Composition |
| WO2003024316A2 (en) * | 2001-09-21 | 2003-03-27 | Stryker Corporation | Pore-forming agents for orthopedic cements |
| GB2384986B (en) * | 2002-02-12 | 2004-01-07 | Reckitt Benckiser Healthcare | Compositions for the treatment of disorders of the upper gastrointestinal tract |
| US7135027B2 (en) * | 2002-10-04 | 2006-11-14 | Baxter International, Inc. | Devices and methods for mixing and extruding medically useful compositions |
| JP4873877B2 (ja) * | 2005-03-30 | 2012-02-08 | 小林製薬株式会社 | アルギン酸ナトリウム含有錠剤の製造方法及び該製造方法により得られる錠剤 |
| RU2527894C2 (ru) | 2007-11-27 | 2014-09-10 | Альгифарма ИПР АС | Использование альгинатных олигомеров в борьбе с биопленками |
| WO2010092468A1 (en) * | 2009-02-13 | 2010-08-19 | Carlo Ghisalberti | Composition comprising alginates and d-limonene to treat gerd and dyspepsia |
| CA2764197C (en) | 2009-06-03 | 2017-09-12 | Algipharma As | Alginate oligomers for use in overcoming multidrug resistance in bacteria |
| CN101933894B (zh) * | 2009-07-03 | 2012-07-11 | 张清 | 胃肠粘膜保护胶 |
| US9186409B2 (en) | 2010-04-23 | 2015-11-17 | S-Biotek Holidng Aps | Solid pharmaceutical composition for neutralizing stomach acid |
| EA201001053A1 (ru) * | 2010-07-08 | 2011-10-31 | Общество С Ограниченной Ответственностью "Вдс" | Состав для профилактики кандидозов |
| DK177435B1 (en) | 2011-06-03 | 2013-05-21 | Biotek Holding Aps S | An aqueous diet product, a unit dosage and a kit comprising at least one alginate, and a method for the preparation of said diet product |
| US9636360B2 (en) | 2012-09-18 | 2017-05-02 | pH Science Holdings, Inc | Method and composition for treating gastro-esophageal disorders |
| WO2014102801A1 (en) * | 2012-12-30 | 2014-07-03 | Hadasit Medical Research Services And Development Ltd. | Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent |
| US11931227B2 (en) | 2013-03-15 | 2024-03-19 | Cook Medical Technologies Llc | Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding |
| ITUB20150279A1 (it) * | 2015-03-09 | 2016-09-09 | S I I T S R L Servizio Int Imballaggi Termosaldanti | Sistema flottante per la cura dei sintomi delle affezioni gastriche |
| WO2019067680A1 (en) | 2017-09-27 | 2019-04-04 | Cook Medical Technologies Llc | CROSSLINKING SUBMUCOSAL INJECTION SYSTEM |
| CA3079695A1 (en) * | 2017-11-08 | 2019-05-16 | Pasquale DEL GAUDIO | In situ gelifying powder |
| CN108451973A (zh) * | 2018-01-30 | 2018-08-28 | 无锡福尔顺科技有限公司 | 一种消化道凝胶保护剂及其使用方法和应用 |
| IT202100000059A1 (it) * | 2021-01-04 | 2022-07-04 | Nyuma Pharma Srl | Nuove composizioni di sucralfato in alginato e loro utilizzo in terapia |
| WO2023018649A1 (en) * | 2021-08-10 | 2023-02-16 | Bayer Healthcare Llc | Liquid formulations comprising alginic acid, pectin, and carrageenan and methods of using thereof for gastric and gastroesophageal disorders |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1524740A (en) * | 1976-11-09 | 1978-09-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions for use in the suppression of gastric reflux |
| GB1566609A (en) * | 1977-03-10 | 1980-05-08 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions containing cholestyramine and alginic acid |
| JPS5746920A (en) * | 1980-09-03 | 1982-03-17 | Kyosei Seiyaku Kk | Drug for digestive tract |
| GB2093697A (en) * | 1980-09-03 | 1982-09-08 | Kyosei Pharmaceutical Co Ltd | Agent for alimentary canal |
| US4869902A (en) * | 1984-04-19 | 1989-09-26 | Rorer Pharmaceutical Corporation | Antacid composition |
| ATE77750T1 (de) * | 1984-04-19 | 1992-07-15 | Rhone Poulenc Rorer Int | Antisaeurezusammensetzung. |
| US4744986A (en) * | 1986-03-07 | 1988-05-17 | Rorer Pharmaceutical Corporation | Process for the preparation of a viscosity-stable antacid composition |
| GB8618847D0 (en) * | 1986-08-01 | 1986-09-10 | Smith Kline French Lab | Pharmaceutical formulations |
| DK179687D0 (da) * | 1987-04-08 | 1987-04-08 | Farma Food As | Praeparat |
| GB9010039D0 (en) * | 1990-05-03 | 1990-06-27 | Reckitt & Colmann Prod Ltd | Medicament preparation |
| GB9218749D0 (en) * | 1992-09-04 | 1992-10-21 | Courtaulds Plc | Alginate gels |
| US5888540A (en) * | 1993-10-29 | 1999-03-30 | Sugden; Keith | Pharmaceutical products |
| GB9504599D0 (en) * | 1995-03-03 | 1995-04-26 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
| GB2298365B (en) * | 1995-03-03 | 1997-05-07 | Reckitt & Colmann Prod Ltd | A liquid pharmaceutical composition alginate and potassium bicarbonate |
-
1998
- 1998-04-23 JP JP54671798A patent/JP2001522368A/ja not_active Ceased
- 1998-04-23 PL PL98336724A patent/PL195031B1/pl not_active IP Right Cessation
- 1998-04-23 PL PL98378779A patent/PL194696B1/pl not_active IP Right Cessation
- 1998-04-23 CN CNB2004100461678A patent/CN1286468C/zh not_active Expired - Fee Related
- 1998-04-23 BR BR9809310-0A patent/BR9809310A/pt not_active Application Discontinuation
- 1998-04-23 AU AU70680/98A patent/AU740972B2/en not_active Expired
- 1998-04-23 KR KR1019997010069A patent/KR20010020438A/ko not_active Withdrawn
- 1998-04-23 PL PL98378778A patent/PL195410B1/pl not_active IP Right Cessation
- 1998-04-23 CA CA002288743A patent/CA2288743C/en not_active Expired - Fee Related
- 1998-04-23 EP EP06024990A patent/EP1842544A3/en not_active Withdrawn
- 1998-04-23 EP EP98917452A patent/EP0979091A1/en not_active Ceased
- 1998-04-23 CN CNB98804594XA patent/CN1197584C/zh not_active Expired - Lifetime
- 1998-04-23 US US09/403,217 patent/US6395307B1/en not_active Expired - Fee Related
- 1998-04-23 ID IDW991279A patent/ID23809A/id unknown
- 1998-04-23 WO PCT/GB1998/001188 patent/WO1998048814A1/en not_active Ceased
- 1998-04-28 ZA ZA983707A patent/ZA983707B/xx unknown
- 1998-04-29 AR ARP980101993A patent/AR012621A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2288743A1 (en) | 1998-11-05 |
| WO1998048814A1 (en) | 1998-11-05 |
| PL195031B1 (pl) | 2007-08-31 |
| CN1552344A (zh) | 2004-12-08 |
| EP1842544A3 (en) | 2007-10-17 |
| CN1253505A (zh) | 2000-05-17 |
| AR012621A1 (es) | 2000-11-08 |
| CA2288743C (en) | 2008-04-22 |
| KR20010020438A (ko) | 2001-03-15 |
| PL194696B1 (pl) | 2007-06-29 |
| PL195410B1 (pl) | 2007-09-28 |
| CN1197584C (zh) | 2005-04-20 |
| AU740972B2 (en) | 2001-11-15 |
| ID23809A (id) | 2000-05-11 |
| AU7068098A (en) | 1998-11-24 |
| PL336724A1 (en) | 2000-07-03 |
| BR9809310A (pt) | 2000-07-04 |
| JP2001522368A (ja) | 2001-11-13 |
| ZA983707B (en) | 1999-02-26 |
| US6395307B1 (en) | 2002-05-28 |
| EP0979091A1 (en) | 2000-02-16 |
| EP1842544A2 (en) | 2007-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1552344A (zh) | 含藻酸或藻酸盐的药物组合物 | |
| CN1039672C (zh) | 用于手和手指的快速干燥的凝胶型消毒剂组合物 | |
| CN1198586C (zh) | 用于递送nsai药物的局部用组合物 | |
| CN1042439C (zh) | 含有变构淀粉的以聚合物为基料的混合组合物及其产品 | |
| CN1261375A (zh) | 由藻酸盐制备糖醛酸嵌段的方法 | |
| CN1081607C (zh) | 二氧化硅和硫酸铝或明矾的含水悬浮液，其制备方法和应用 | |
| CN1544084A (zh) | 肽的延长释放 | |
| CN1353574A (zh) | 基于h2o2、酸和金属离子的消毒组合物 | |
| CN1021911C (zh) | 取代的噻吩并咪唑衍生物的制备方法 | |
| CN1334862A (zh) | 制备可浇注的、具有连续悬浮体系的透明/半透明液体洗涤剂的方法 | |
| CN1267220A (zh) | 凝胶化组合物 | |
| CN1668270A (zh) | 含有粉末的水包油型乳化组合物 | |
| CN1882353A (zh) | 催涎剂和混合该催涎剂的口腔用组合物以及食品组合物 | |
| CN1319597C (zh) | 含多糖组合物及其用途 | |
| CN1126548C (zh) | 透明质酸锌抗消化性溃疡的应用 | |
| CN1420844A (zh) | 金属硅酸盐、纤维素产品及其工艺 | |
| CN1780880A (zh) | 可增稠的组合物 | |
| CN85104754A (zh) | 制酸组成物的制造方法 | |
| CN1835726A (zh) | 二氧化碳外用凝胶调制用组合物和二氧化碳外用凝胶 | |
| CN1265798C (zh) | 含有藻酸盐的药物组合物 | |
| CN1361819A (zh) | 液态擦洗剂组合物 | |
| CN1771902A (zh) | 多功能保健牙膏及其生产工艺 | |
| CN1254254A (zh) | 用于刺激花粉粒萌发的组合物和方法 | |
| FR2668031A1 (fr) | Bouillies bordelaises et leur procede de preparation. | |
| CN1026097C (zh) | 新型陶瓷材料组合物及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061129 Termination date: 20100423 |